Literature DB >> 2387091

Antibody binding and inhibition of pyruvate dehydrogenase (PDH) in sera from patients with primary biliary cirrhosis.

U Sundin1.   

Abstract

Autoantibodies reactive against mitochondria which are present in sera from patients with primary biliary cirrhosis (PBC) have been shown to bind to the lipoamide acetyltransferase moiety (E2) of the pyruvate dehydrogenase enzyme complex (PDH). This newly described antigen has been shown to be identical to M2, a 70-kD antigen of the inner mitochondrial membrane. Sera from 10 patients with PBC, 11 patients with chronic active hepatitis (CAH), 20 healthy controls and patients with thyroiditis and systemic lupus erythematosus (SLE) were tested by ELISA for the presence of antibodies (IgG and IgM classes and IgG subclasses) reactive against PDH. The effect of serum and separated IgG and IgM on the PDH enzyme activity was measured spectrophotometrically. Nine out of 10 PBC sera were positive by immunofluorescence for mitochondria (M2 pattern). These nine sera reacted strongly with both IgG and IgM to PDH in the ELISA and also inhibited the enzyme activity by 80% (s.d. 25%). This was significantly different compared with the controls (4 +/- 6%; P less than 0.001). Enzyme inhibition was mainly caused by IgG. Of all control sera (from healthy and patient individuals) only one patient with CAH reacted significantly in the tests. This CAH patient had a high antibody titre against mitochondria as measured by immunofluorescence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387091      PMCID: PMC1535059          DOI: 10.1111/j.1365-2249.1990.tb03324.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Primary biliary cirrhosis: assessment of the quantitative importance of the adenine nucleotide translocator protein as a major mitochondrial antigen.

Authors:  I Mendel-Hartvig; A Frostell; B D Nelson
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

2.  Primary biliary cirrhosis: indication for a single mitochondrial antigenic epitope detected by patient autoantibodies and a novel monoclonal antibody.

Authors:  I Mendel-Hartvig; A Björkland; B D Nelson; R Norberg; U Ytterström; T H Tötterman
Journal:  Scand J Immunol       Date:  1988-10       Impact factor: 3.487

Review 3.  IgG subclass changes in response to vaccination.

Authors:  L Hammarström; C I Smith
Journal:  Monogr Allergy       Date:  1986

4.  HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.

Authors:  G Ballardini; F B Bianchi; R Mirakian; M Fallani; E Pisi; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

5.  Primary biliary cirrhosis: further biochemical and immunological characterization of mitochondrial antigens.

Authors:  I Mendel-Hartvig; B D Nelson; L Lööf; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

6.  Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis.

Authors:  U Spengler; G R Pape; R M Hoffmann; J P Johnson; J Eisenburg; G Paumgartner; G Riethmüller
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

7.  Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase.

Authors:  R L Coppel; L J McNeilage; C D Surh; J Van de Water; T W Spithill; S Whittingham; M E Gershwin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

8.  Purification and some properties of streptococcal protein G, a novel IgG-binding reagent.

Authors:  L Björck; G Kronvall
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

9.  Is mitochondrial antibody diagnostic of primary biliary cirrhosis?

Authors:  L E Munoz; H C Thomas; P J Scheuer; D Doniach; S Sherlock
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

10.  The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase.

Authors:  J Van de Water; M E Gershwin; P Leung; A Ansari; R L Coppel
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Primary biliary cirrhosis. Connecting molecular biology to clinical medicine.

Authors:  S Reynoso-Paz; R L Coppel; Y Nakanuma; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Class and subclass-associated specificity differences of anti-gliadin antibodies from mucosa and serum.

Authors:  P E Engström; U Sundin; B Lavö; G Norhagen; R Hällgren; C I Smith; L Hammarström
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

3.  Plasma membrane association of primary biliary cirrhosis mitochondrial marker antigen M2.

Authors:  U Sundin; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

4.  Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis.

Authors:  P S Leung; S Krams; S Munoz; C P Surh; A Ansari; T Kenny; D L Robbins; J Fung; T E Starzl; W Maddrey
Journal:  J Autoimmun       Date:  1992-12       Impact factor: 7.094

5.  Role of immunoglobulin G subclasses in Q fever.

Authors:  M T Camacho; I Outschoorn; A Tellez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

6.  Isotypic distribution of anti-pyruvate dehydrogenase antibodies in patients with primary biliary cirrhosis and their family members.

Authors:  R Maran; M Dueymes; Y Adler; Y Shoenfeld; P Youinou
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

7.  Aspartate aminotransferase-linked immunoglobulin complexes in serum of a patient with primary biliary cirrhosis.

Authors:  Y Matsuda; Y Amuro; T Hada; K Higashino; N Ueki; M Fujikura; A Tonomura; T Yamamoto; K Yamaguchi; S Shimomura
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.